Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy Clinical research trials and Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy. Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy clinical trial. Subjects frequently get the best healthcare possible for their Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.

Home > "F" Clinical Trials Conditions > Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy

Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy



Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy

For Condition: Healthy,Nervous System Disease
Status: Completed
Sponsor(s): Warren G Magnuson Clinical Center (CC) ,
Synopsis: Technical advances in magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) have provided researchers with the opportunity to study changes of the central nervous system (CNS) and improve diagnosis and therapy of CNS disease. New MRI and MRS techniques specifically designed for functional MRI (fMRI) and MRS imaging of the CNS will be evaluated in normal volunteers and in patients with CNS diseases. This study will develop and evaluate new magnetic resonance pulse sequences for performing MRI or MRS and compare the results to existing MR techniques. Patients and volunteers age 18 and older are eligible for the study. A history will be taken in which exclusion criteria (such as having a pacemaker or cochlear implants) will be addressed, and a pregnancy test will be administered to women of childbearing age. Each subject will also be asked to fill out a questionnaire. Study participants will lie in the MRI scanner from 20 minutes to 2 hours. A coil may be placed on the head and participants may be asked to do simple or complex tasks. A catheter will be placed in an arm vein and a contrast agent will be administered. This agent will allow structures in the brain to show up more clearly.
Details: Technical advances in Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) have provided researchers with the opportunity to study functional and metabolic changes of the central nervous system (CNS) in both normal individuals and individuals with neurological diseases in response to sensory, motor or cognitive stimulation. New MRI and MRS techniques specifically designed for Functional Magnetic Resonance Imaging (fMRI) and Magnetic Resonance Spectroscopic Imaging of the CNS will be evaluated at 1.5 and/or at 4.0 Tesla on normal volunteers and in patients with CNS pathology.
Eligibility:
Study Type:  Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Any normal volunteer age 18 and over who is capable of giving informed consent. For the purposes of evaluating new techniques for fMRI, patients will be considered the same as volunteers. EXCLUSION CRITERIA: A subject will be excluded if he/she has a contraindication to MR scanning such as the following: aneurysm clip; implanted neural stimulator; implanted cardiac pacemaker or autodefibrillator; cochlear implant; ocular foreign body or implant (e.g., metal shavings, retinal clips); breast implants or Insulin pump. Subjects who have a history of a reaction to MR contrast agents specifically gadopentetate dimeglumine will be excluded from participating in the contrast agent administration part of this protocol. The contraindications to MRI at 1.5 Tesla and 4 Tesla are identical.
Total Enrollment: 450

Location and Contact Information:

Warren G. Magnuson Clinical Center (CC)
Bethesda,  Maryland,  20892
United States
 


Additional Information:
Study ID Numbers:  970152;  97-CC-0152
Study Start Date: July 17, 1997
Record last reviewed: July 7, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001591

Other Nervous System Disease Studies:
1. Sleep Disorders of Patients with Diseases of the Nervous System

2. Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy

3. Genetic Studies in Alzheimer's Disease

4. Treatment of Cortical Myoclonus with Repetitive Transcranial Magnetic Stimulation

5. (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy

Related Studies:

Other Nervous System Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials

Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy
Modify your Search

  Other Nervous System Disease Clinical Trials
  Other Maryland Clinical Trials
  Other Bethesda Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103